These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 2967756)
21. [Neurotransmitter anomalies in Alzheimer's disease]. Berger B Rev Neurol (Paris); 1984; 140(10):539-52. PubMed ID: 6150545 [TBL] [Abstract][Full Text] [Related]
22. Disease targets and strategies for the therapeutic modulation of endogenous neural stem and progenitor cells. Goldman SA Clin Pharmacol Ther; 2007 Oct; 82(4):453-60. PubMed ID: 17713467 [TBL] [Abstract][Full Text] [Related]
23. Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies. Mosimann UP; Müri RM; Burn DJ; Felblinger J; O'Brien JT; McKeith IG Brain; 2005 Jun; 128(Pt 6):1267-76. PubMed ID: 15774501 [TBL] [Abstract][Full Text] [Related]
24. Biochemical substrates of mental disturbances in Parkinson's disease. Agid Y; Ruberg M; Dubois B; Javoy-Agid F Adv Neurol; 1984; 40():211-8. PubMed ID: 6695597 [No Abstract] [Full Text] [Related]
25. Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease. Kuhl DE; Markham CH; Metter EJ; Riege WH; Phelps ME; Mazziotta JC Res Publ Assoc Res Nerv Ment Dis; 1985; 63():199-209. PubMed ID: 3161165 [TBL] [Abstract][Full Text] [Related]
26. Putative peptide neurotransmitters in human neuropathology: a review of topography and clinical implications. Constantinidis J; Bouras C; Richard J Clin Neuropathol; 1983; 2(2):47-54. PubMed ID: 6189657 [TBL] [Abstract][Full Text] [Related]
27. The contribution of the study of neurodegenerative disorders to the understanding of human memory. Panegyres PK QJM; 2004 Sep; 97(9):555-67. PubMed ID: 15317924 [TBL] [Abstract][Full Text] [Related]
28. The dementias of Parkinson's disease: prevalence, characteristics, neurobiology, and comparison with dementia of the Alzheimer type. Cummings JL Eur Neurol; 1988; 28 Suppl 1():15-23. PubMed ID: 3288478 [TBL] [Abstract][Full Text] [Related]
29. Magnetic resonance imaging and magnetic resonance spectroscopy in dementias. Hsu YY; Du AT; Schuff N; Weiner MW J Geriatr Psychiatry Neurol; 2001; 14(3):145-66. PubMed ID: 11563438 [TBL] [Abstract][Full Text] [Related]
30. Yeast as a drug discovery platform in Huntington's and Parkinson's diseases. Outeiro TF; Giorgini F Biotechnol J; 2006 Mar; 1(3):258-69. PubMed ID: 16897706 [TBL] [Abstract][Full Text] [Related]
32. Involvement of non-opioid peptides in the pathogenesis of neurological and psychiatric disorders: evidence from CSF and post-mortem studies. Nemeroff CB; Bissette G Prog Clin Biol Res; 1985; 192():333-41. PubMed ID: 2934745 [TBL] [Abstract][Full Text] [Related]
33. Network biomarkers for the diagnosis and treatment of movement disorders. Poston KL; Eidelberg D Neurobiol Dis; 2009 Aug; 35(2):141-7. PubMed ID: 19013242 [TBL] [Abstract][Full Text] [Related]
34. Letter and semantic fluency in Alzheimer's, Huntington's, and Parkinson's dementias. Suhr JA; Jones RD Arch Clin Neuropsychol; 1998 Jul; 13(5):447-54. PubMed ID: 14590609 [TBL] [Abstract][Full Text] [Related]
35. Biomarkers in Huntington's and Parkinson's Disease. O'Keeffe GC; Michell AW; Barker RA Ann N Y Acad Sci; 2009 Oct; 1180():97-110. PubMed ID: 19906264 [TBL] [Abstract][Full Text] [Related]
36. Normal CAG and CCG repeats in the Huntington's disease genes of Parkinson's disease patients. Rubinsztein DC; Leggo J; Goodburn S; Barton DE; Ferguson-Smith MA Am J Med Genet; 1995 Apr; 60(2):109-10. PubMed ID: 7485243 [TBL] [Abstract][Full Text] [Related]
37. Recent developments in Parkinson's disease and Huntington's chorea. Barbeau A Int J Neurol; 1976; 11(1):17-27. PubMed ID: 138661 [No Abstract] [Full Text] [Related]